Executive record

Jay Birnbaum

Director at Sonoma Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:jay-birnbaumVersion: public-0As of: 2026-09-29

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Dr. Birnbaum is a pharmacologist who has served as a consultant to pharmaceutical companies since 1999. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals and was co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals. He has extensive experience in pharmaceutical development and strategic planning.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. SNOA DEF 14A director slate

    sec filing · Source published: Jul 11, 2025 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation, Nominating/Governance · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Jul 11, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Sonoma Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Sonoma Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026